Medicare Coverage for COVID-19 After May 11, 2023
Even after the Public Health Emergency for COVID-19 ended, Medicare continues to provide coverage for various COVID-19-related services.
This summary highlights the key COVID-19 services that Medicare continues to cover, ensuring you receive necessary care with minimal out-of-pocket costs.
1. Vaccines
- COVID-19 Vaccines: Medicare covers all FDA-authorized and FDA-approved COVID-19 vaccines at no cost to you.
2. Diagnostic Testing
- COVID-19 Diagnostic Tests: Medicare Part B covers COVID-19 lab tests without cost sharing when ordered by a healthcare provider and conducted in a laboratory. However, some Medicare Advantage Plans may require you to pay part of the cost.
3. Treatments
- Oral Antivirals: If you test positive for COVID-19 and have mild to moderate symptoms but are at high risk of severe illness, you may be eligible for oral antiviral treatment. Medicare Part D covers these treatments, but your plan's deductible, copayment, and coinsurance rules will apply.
- Monoclonal Antibody Treatments: Medicare covers monoclonal antibody treatments for COVID-19 as needed.
- Antibody Tests: Medicare covers FDA-authorized COVID-19 antibody tests if you have or had a COVID-19 infection or are suspected of having one.
4. Hospitalization
- Medically Necessary Hospitalizations: Medicare covers all necessary hospital stays related to COVID-19. This includes extended stays if you need to remain in the hospital under quarantine. Standard hospital deductibles, copays, and coinsurance still apply.
5. Telehealth Services
- Telehealth Services: Medicare has extended coverage for telehealth services through December 31, 2024, allowing you to access care remotely.
Stay up to date regarding the latest public & safety information from the CDC - https://www.cdc.gov/covid/
